Obesity trials in Mexico

In Mexico 42 Also abroad 1939

42 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Ciudad Madero, Col Saucito, Cuernavaca, Delegacion Cuauhtemoc, Guadalajara, México, San Pedro Garza García
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Ciudad Madero, Col Saucito, Cuernavaca, Delegacion Cuauhtemoc, Guadalajara, México, San Pedro Garza García
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Cuernavaca, Mexico City, Monterrey
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Where
Ciudad Madero, Culiacán, Guadalajara, Mérida, Mexico City, Monterrey, San Nicolás de los Garza, Tlalpan
Age
18 years and over
People
2,001 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00
Phase 3Taking people
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Where
Culiacán, Guadalajara, Juriquilla, León, Mexico City, Puebla City
Age
6 years to 17 years
People
125 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06672549
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mérida, Mexico City, Monterrey, Morelia, Puebla City, Tlalnepantla, Veracruz
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Aguascalientes, Chihuahua City, Ciudad Madero, Durango, Guadajalara, Guadalajara, Juriquilla, Mérida, Mexico City, Monterrey, Morelia, Puebla City, Tlalnepantla, Veracruz
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Where
Chihuahua City, Ciudad Madero, Juriquilla, Mérida, México, Mexico City, Monterrey, Morelia, Tlalpan
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Guadalajara, Mérida, Monterrey
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Chihuahua City, Guadalajara, Huixquilucan, Mexicali, Mexico City, Monterrey
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Where
Guadalajara, León, Monterrey, Querétaro
Age
6 years to 11 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00
Phase 3Not yet taking people in Mexico
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Actopan, Cuernavaca, Culiacán, Durango, Guadalajara, León, México, Mexico City, Monterrey, Querétaro
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
No phaseEnrolling by invitation
Impact of a Playful Family Education Strategy With ICT on Childhood Obesity Prevention
Where
Mexico City
Age
6 years to 12 years
People
200
Run by
Instituto Mexicano del Seguro Social
See details and how to joinNCT06486493
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Aguascalientes, Culiacán, Juriquilla, Mexico City, Monterrey, Querétaro City
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
No phaseTaking people
Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children.
Where
México
Age
5 years to 9 years
People
40
Run by
Claudia Teresa Tovar Palacio
See details and how to joinNCT07159971
Phase 3Not yet taking people in Mexico
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Actopan, Aguascalientes, Chihuahua City, Col. Roma Norte, Cuauhtémoc, Guadalajara, Mérida, Mexico City, Monterrey, Puebla City, San Nicolás de los Garza, Tlalpan, Veracruz de Ignacio de La Llave, Xalapa
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 3Taking people
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Where
Monterrey, Puebla City
Age
8 years to 18 years
People
460 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00
No phaseTaking people
Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes
Where
Mexico City
Age
18 years and over
People
200
Run by
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
See details and how to joinNCT07835360
Phase 3Taking people
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Where
Aguascalientes, Guadalajara, Monterrey, Puebla City
Age
12 years to 17 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06439277
No phaseTaking people
Lactobacillus Acidophilus and Inulin for Cognitive Impairment in Obesity
Where
Huixquilucan
Age
30 years to 40 years
People
40
Run by
Anahuac University
See details and how to joinNCT07810517
No phaseNot yet taking people in Mexico
Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With Obesity
Where
Cuernavaca
Age
40 years to 59 years
People
192
Run by
Autonomous University of Morelos
See details and how to joinNCT07782411
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Actopan, Chihuahua City, Ciudad Madero, Col. Roma Norte, Col. Zona Comercial Plaza Del Sol, Cuauhtémoc, Guadalajara, León, Mérida, Monterrey, Oaxaca City, Querétaro City, San Luis Potosí City, San Nicolás de los Garza, Tlalpan, Torreón, Xalapa
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Where
Guadalajara
Age
18 years and over
People
250 worldwide
Run by
Rush University Medical Center
See details and how to joinNCT05918575
Phase 4Taking people
Fibrosis Lessens After Metabolic Surgery
Where
Mexico City
Age
18 years to 75 years
People
120 worldwide
Run by
The Cleveland Clinic
See details and how to joinNCT06374875
Phase 3Not yet taking people in Mexico
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
Where
Ciudad Madero, Guadalajara, Hermosillo, Mexico City, Morelia, Querétaro City
Age
18 years and over
People
352
Run by
Carnot Laboratories
See details and how to joinNCT07622810